News

US gene discovery leads to patent war

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7043.1378b (Published 01 June 1996) Cite this as: BMJ 1996;312:1378

The finding of the association of a human gene with breast cancer has suddenly turned into a patent war in the US. Myriad Genetics, the Utah biotechnology firm that in 1994 isolated the BRCA1 gene that is strongly associated with breast cancer, is now seeking to patent the gene. The company says that it will soon begin selling a test kit for $900 (£590) that will show …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe